货号:A423241
同义名:
Ro 15-1788;Ro 1722
Flumazenil是一种非选择性的苯二氮卓类药物拮抗剂,能够拮抗含有 α1、α2、α3 或 α5 的 GABAA 受体,具有解毒作用,常用于苯二氮卓类过量问题。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | GABA receptor ↓ ↑ | GABAA receptor ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Niflumic Acid | ✔ | 98% | |||||||||||||||||
Ginkgolide A |
++
GABA receptor, Ki: 14.5 μM |
98% | |||||||||||||||||
Valproic acid sodium | ✔ | Autophagy,HDAC | 97% | ||||||||||||||||
Flumazenil | ✔ | 95% | |||||||||||||||||
Bemegride | ✔ | 98% | |||||||||||||||||
Bicuculline |
+++
GABAA receptor, IC50: 2 μM |
99% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | Flumazenil, an imidazobenzodiazepine derivative, is an antagonist of the GABA/benzodiazepines receptor complex that might play a role in the treatment of hepatic encephalopathy[3]. Flumazenil can antagonize the hypnotic and sedative effects of benzodiazepines at gamma-amino butyric acid receptors. Flumazenil could be considered in cases in which quick recovery is required and should be administered intravenously in small, incremental doses[4]. Intravenous antagonist doses of 0.2 mg followed by 0.1 mg/min to a total dose of 1 mg have produced significant results in reversing benzodiazepine sedation. As much as 5 mg of flumazenil have been necessary when treating benzodiazepine or mixed-agent intoxications. Flumazenil is well tolerated locally as well as systemically[5]. Because flumazenil appears to be specific in its antagonism of benzodiazepine-induced respiratory and CNS depression, it could be used empirically to confirm or exclude a role of benzodiazepines in the generation of mental status changes in the setting of overdose or coma of unknown origin[6]. |
[4]Mizuno J. [Flumazenil]. Masui. 2013 Jan;62(1):10-8.
[5]Karavokiros KA, Tsipis GB. Flumazenil: a benzodiazepine antagonist. DICP. 1990 Oct;24(10):976-81
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.30mL 0.66mL 0.33mL |
16.49mL 3.30mL 1.65mL |
32.97mL 6.59mL 3.30mL |
CAS号 | 78755-81-4 |
分子式 | C15H14FN3O3 |
分子量 | 303.29 |
别名 | Ro 15-1788;Ro 1722;Flumazenil, Flumazepil, Anexate, Romazicon, Lanexat, Ro 15-1788, Ro 15 1788, Ro 151788;Ro 41-8157 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
DMSO: 18 mg/mL(59.35 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |